GLRA4 anticorps (Cy7)
Aperçu rapide pour GLRA4 anticorps (Cy7) (ABIN1412988)
Antigène
Voir toutes GLRA4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human GLRA4
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IF(IHC-P)(1:50-200)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- GLRA4 (Glycine Receptor, alpha 4 (GLRA4))
-
Autre désignation
- Glra4
-
Sujet
-
Synonyms: Glra4, GLRA4_HUMAN, Glycine receptor subunit alpha-4, Glycine receptor, alpha 4.
Background: The glycine receptor is a neurotransmitter-gated ion channel. Binding of glycine to its receptor increases the chloride conductance and thus produces hyperpolarization (inhibition of neuronal firing).
Antigène
-